China Universal Asset Management Company’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $690K | Buy |
18,988
+434
| +2% | +$15.8K | 0.07% | 216 |
|
|
2025
Q1 | $672K | Sell |
18,554
-1,026
| -5% | -$37.2K | 0.06% | 215 |
|
|
2024
Q4 | $824K | Buy |
19,580
+1,854
| +10% | +$78K | 0.08% | 188 |
|
|
2024
Q3 | $985K | Buy |
17,726
+7,960
| +82% | +$442K | 0.11% | 140 |
|
|
2024
Q2 | $401K | Sell |
9,766
-6,051
| -38% | -$249K | 0.06% | 166 |
|
|
2024
Q1 | $738K | Buy |
15,817
+6,316
| +66% | +$295K | 0.09% | 147 |
|
|
2023
Q4 | $454K | Buy |
9,501
+7,670
| +419% | +$367K | 0.09% | 151 |
|
|
2023
Q3 | $65.3K | Buy |
1,831
+903
| +97% | +$32.2K | 0.02% | 222 |
|
|
2023
Q2 | $42.8K | Sell |
928
-23
| -2% | -$1.06K | 0.01% | 207 |
|
|
2023
Q1 | $38.1K | Buy |
951
+239
| +34% | +$9.58K | 0.01% | 171 |
|
|
2022
Q4 | $33K | Buy |
712
+56
| +9% | +$2.59K | 0.01% | 153 |
|
|
2022
Q3 | $27K | Buy |
+656
| New | +$27K | 0.01% | 141 |
|